CLINICAL_TRIALS
trial_result
· 2026-06-30
Clinical Trial Results: Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection [Phase 2]
Summary
Phase 2 trial results for Obeldesivir in nonhospitalized adults with RSV infection have been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: RSV Infection | Phase 2 | Status: TERMINATED | Results posted: 2026-06-30